BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1105 related articles for article (PubMed ID: 28445460)

  • 1. Polyglutamine tracts regulate beclin 1-dependent autophagy.
    Ashkenazi A; Bento CF; Ricketts T; Vicinanza M; Siddiqi F; Pavel M; Squitieri F; Hardenberg MC; Imarisio S; Menzies FM; Rubinsztein DC
    Nature; 2017 May; 545(7652):108-111. PubMed ID: 28445460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyglutamine tracts regulate autophagy.
    Ashkenazi A; Bento CF; Ricketts T; Vicinanza M; Siddiqi F; Pavel M; Squitieri F; Hardenberg MC; Imarisio S; Menzies FM; Rubinsztein DC
    Autophagy; 2017 Sep; 13(9):1613-1614. PubMed ID: 28722507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward therapeutic targets for SCA3: Insight into the role of Machado-Joseph disease protein ataxin-3 in misfolded proteins clearance.
    Li X; Liu H; Fischhaber PL; Tang TS
    Prog Neurobiol; 2015 Sep; 132():34-58. PubMed ID: 26123252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Praja1 ubiquitin ligase facilitates degradation of polyglutamine proteins and suppresses polyglutamine-mediated toxicity.
    Ghosh B; Karmakar S; Prasad M; Mandal AK
    Mol Biol Cell; 2021 Aug; 32(17):1579-1593. PubMed ID: 34161122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyglutamine expansion diseases: More than simple repeats.
    Silva A; de Almeida AV; Macedo-Ribeiro S
    J Struct Biol; 2018 Feb; 201(2):139-154. PubMed ID: 28928079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allele-selective lowering of mutant HTT protein by HTT-LC3 linker compounds.
    Li Z; Wang C; Wang Z; Zhu C; Li J; Sha T; Ma L; Gao C; Yang Y; Sun Y; Wang J; Sun X; Lu C; Difiglia M; Mei Y; Ding C; Luo S; Dang Y; Ding Y; Fei Y; Lu B
    Nature; 2019 Nov; 575(7781):203-209. PubMed ID: 31666698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The deubiquitinase ataxin-3 requires Rad23 and DnaJ-1 for its neuroprotective role in Drosophila melanogaster.
    Tsou WL; Ouyang M; Hosking RR; Sutton JR; Blount JR; Burr AA; Todi SV
    Neurobiol Dis; 2015 Oct; 82():12-21. PubMed ID: 26007638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3.
    Zeng L; Wang B; Merillat SA; Minakawa EN; Perkins MD; Ramani B; Tallaksen-Greene SJ; Costa MDC; Albin RL; Paulson HL
    Neurobiol Dis; 2015 Oct; 82():281-288. PubMed ID: 26141599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and Characterization of Knock-in Mouse Models Expressing Versions of Huntingtin with Either an N17 or a Combined PolyQ and Proline-Rich Region Deletion.
    André EA; Braatz EM; Liu JP; Zeitlin SO
    J Huntingtons Dis; 2017; 6(1):47-62. PubMed ID: 28211815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquilin-2 differentially regulates polyglutamine disease proteins.
    Gerson JE; Safren N; Fischer S; Patel R; Crowley EV; Welday JP; Windle AK; Barmada S; Paulson HL; Sharkey LM
    Hum Mol Genet; 2020 Aug; 29(15):2596-2610. PubMed ID: 32681165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fine balance between Prpf19 and Exoc7 in achieving degradation of aggregated protein and suppression of cell death in spinocerebellar ataxia type 3.
    Chen ZS; Huang X; Talbot K; Chan HYE
    Cell Death Dis; 2021 Feb; 12(2):136. PubMed ID: 33542212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
    Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
    Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coiled-coil structure-dependent interactions between polyQ proteins and Foxo lead to dendrite pathology and behavioral defects.
    Kwon MJ; Han MH; Bagley JA; Hyeon DY; Ko BS; Lee YM; Cha IJ; Kim SY; Kim DY; Kim HM; Hwang D; Lee SB; Jan YN
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):E10748-E10757. PubMed ID: 30348793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PolyQ-expanded huntingtin and ataxin-3 sequester ubiquitin adaptors hHR23B and UBQLN2 into aggregates via conjugated ubiquitin.
    Yang H; Yue HW; He WT; Hong JY; Jiang LL; Hu HY
    FASEB J; 2018 Jun; 32(6):2923-2933. PubMed ID: 29401586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herp Promotes Degradation of Mutant Huntingtin: Involvement of the Proteasome and Molecular Chaperones.
    Luo H; Cao L; Liang X; Du A; Peng T; Li H
    Mol Neurobiol; 2018 Oct; 55(10):7652-7668. PubMed ID: 29430620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PolyQ-expanded proteins impair cellular proteostasis of ataxin-3 through sequestering the co-chaperone HSJ1 into aggregates.
    Yue HW; Hong JY; Zhang SX; Jiang LL; Hu HY
    Sci Rep; 2021 Apr; 11(1):7815. PubMed ID: 33837238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the polyglutamine protein ataxin-3 with Rad23 regulates toxicity in Drosophila models of Spinocerebellar Ataxia Type 3.
    Sutton JR; Blount JR; Libohova K; Tsou WL; Joshi GS; Paulson HL; Costa MDC; Scaglione KM; Todi SV
    Hum Mol Genet; 2017 Apr; 26(8):1419-1431. PubMed ID: 28158474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H1152 promotes the degradation of polyglutamine-expanded ataxin-3 or ataxin-7 independently of its ROCK-inhibiting effect and ameliorates mutant ataxin-3-induced neurodegeneration in the SCA3 transgenic mouse.
    Wang HL; Hu SH; Chou AH; Wang SS; Weng YH; Yeh TH
    Neuropharmacology; 2013 Jul; 70():1-11. PubMed ID: 23347954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity and aggregation of the polyglutamine disease protein, ataxin-3 is regulated by its binding to VCP/p97 in Drosophila melanogaster.
    Ristic G; Sutton JR; Libohova K; Todi SV
    Neurobiol Dis; 2018 Aug; 116():78-92. PubMed ID: 29704548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T1-11 and JMF1907 ameliorate polyglutamine-expanded ataxin-3-induced neurodegeneration, transcriptional dysregulation and ataxic symptom in the SCA3 transgenic mouse.
    Chou AH; Chen YL; Chiu CC; Yuan SJ; Weng YH; Yeh TH; Lin YL; Fang JM; Wang HL
    Neuropharmacology; 2015 Dec; 99():308-17. PubMed ID: 26254860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.